ACHE and Alzheimer disease: AChE has indeed for many years been implicated and pharmaceutically targeted in AD and more recently in the formation of amyloid, by virtue of its enzymatic action: in contrast the C-terminal peptide would appear to operate in a non-cholinergic role as an independent entity.